BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 75 filers reported holding BRIDGEBIO PHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $759,900 | -62.4% | 30,000 | -40.0% | 0.00% | -60.0% |
| Q4 2023 | $2,018,500 | +1353.8% | 50,000 | +849.7% | 0.01% | – |
| Q3 2023 | $138,843 | -87.9% | 5,265 | -92.1% | 0.00% | -100.0% |
| Q2 2023 | $1,146,793 | -48.4% | 66,674 | -50.3% | 0.00% | -57.1% |
| Q1 2023 | $2,224,605 | +0.1% | 134,174 | +0.7% | 0.01% | -12.5% |
| Q4 2021 | $2,222,000 | +524.2% | 133,212 | +909.2% | 0.01% | +300.0% |
| Q2 2019 | $356,000 | – | 13,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $60,317,000 | 40.05% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $308,746,000 | 6.20% |
| M28 Capital Management LP | 513,300 | $5,102,000 | 5.33% |
| GREAT POINT PARTNERS LLC | 1,050,000 | $10,437,000 | 2.51% |
| Octagon Capital Advisors LP | 933,743 | $9,281,000 | 1.60% |
| HHLR ADVISORS, LTD. | 5,362,014 | $53,298,000 | 1.40% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $264,613,000 | 1.22% |
| Cormorant Asset Management, LP | 1,469,179 | $14,604,000 | 1.02% |
| Fernwood Investment Management, LLC | 204,550 | $2,033,000 | 0.86% |
| TANG CAPITAL MANAGEMENT LLC | 585,424 | $5,819,000 | 0.71% |